CPT® Code 83894

Code deleted, see 81200-81479

Official Description

Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation

Common Language Description

Molecular diagnostics encompass a range of tests designed to identify genetic mutations that may indicate the presence of specific diseases, even in asymptomatic patients. These tests play a crucial role in diagnosing and monitoring existing disease states, as well as in screening individuals who may be carriers of genetic conditions or predisposed to certain health issues, thereby guiding preventive medical interventions. The nucleic acid preparations utilized in these tests can vary, including undigested nucleic acids, digestates, or specially modified samples such as newly synthesized oligonucleotides. A key technique employed in molecular diagnostics is gel electrophoresis, where genetic material is introduced into wells within a gel matrix. This gel serves to contain and separate target molecules based on their size when an electric current is applied. The choice of gel—whether agarose or polyacrylamide—depends on the weight and composition of the nucleic acids being analyzed. Smaller nucleic acids, such as DNA, RNA, and oligonucleotides, are typically separated using polyacrylamide gels, while larger nucleic acids, which consist of several hundred bases or more, are analyzed using agarose gels. As the electric current passes through the gel, the nucleic acid molecules migrate at varying rates according to their mass, allowing for effective separation. Following this process, the molecules can be stained to enhance visibility, facilitating further analysis or preparation for additional methods, such as DNA sequencing or Southern blotting. The CPT® Code 83894 is specifically reported for each nucleic acid preparation processed through this method.

1. Indications

The molecular diagnostics procedure utilizing CPT® Code 83894 is indicated for various clinical scenarios, including:

Detection of Genetic Mutations - This procedure is performed to identify genetic mutations that may be associated with specific diseases, even in patients who do not exhibit any symptoms.
Monitoring Disease States - It is used to monitor existing disease conditions, providing valuable information regarding the progression or response to treatment.
Screening for Genetic Carriers - The procedure aids in screening individuals who may be carriers of genetic diseases, which is crucial for family planning and preventive healthcare.
Assessment of Predisposition to Conditions - It is also indicated for assessing individuals who may be predisposed to certain genetic conditions, allowing for timely preventive measures.

2. Procedure

The procedure for molecular diagnostics using CPT® Code 83894 involves several key steps:

Preparation of Nucleic Acids - The first step involves preparing the nucleic acid samples, which may include undigested nucleic acids, digestates, or specially modified samples such as newly synthesized oligonucleotides. This preparation is critical for ensuring that the samples are suitable for analysis.
Loading the Gel - Once the nucleic acids are prepared, they are loaded into wells created in a gel matrix. The type of gel used—agarose or polyacrylamide—is selected based on the size and composition of the nucleic acids being analyzed.
Application of Electric Current - An electric current is then applied to the gel, causing the nucleic acid molecules to migrate through the porous matrix. The rate of movement is determined by the size of the molecules, with smaller nucleic acids moving faster than larger ones.
Staining for Visualization - After the electrophoresis process is complete, the nucleic acids are stained to enhance their visibility. This step is essential for analyzing the results and determining the presence of specific genetic markers.
Analysis and Further Characterization - The separated nucleic acids can be analyzed directly or used as a preparatory step for additional methods, such as DNA sequencing or Southern blotting, to provide further characterization of the genetic material.

3. Post-Procedure

Post-procedure care for molecular diagnostics involving CPT® Code 83894 typically includes monitoring the results of the gel electrophoresis and interpreting the data obtained from the analysis. It is important to ensure that the results are documented accurately for clinical decision-making. Depending on the findings, further testing or follow-up may be required to confirm diagnoses or to guide treatment options. Additionally, healthcare providers may need to discuss the implications of the results with patients, especially in cases where genetic predispositions or carrier statuses are identified.

Short Descr	MOLECULE GEL ELECTROPHOR
Medium Descr	MOLEC SEP GEL ELECTROPHORESIS EACH PREPJ
Long Descr	Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation
Status Code	Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days	XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC)	9 - Not Applicable
Multiple Procedures (51)	9 - Concept does not apply.
Bilateral Surgery (50)	9 - Concept does not apply.
Physician Supervisions	09 - Concept does not apply.
Assistant Surgeon (80, 82)	9 - Concept does not apply.
Co-Surgeons (62)	9 - Concept does not apply.
Team Surgery (66)	9 - Concept does not apply.
Diagnostic Imaging Family	99 - Concept Does Not Apply
APC Status Indicator	Discontinued Code
Type of Service (TOS)	5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS)	none
MUE	Not applicable/unspecified.
CCS Clinical Classification	233 - Laboratory - Chemistry and Hematology